✦ LIBER ✦

Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story

✍ Scribed by Pier Alberto Testoni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1523 Pancreatic Stents and Pharmacolog

✍ Akshintala, Venkata S.; Hutfless, Susan; Law, Joanna K.; Kim, Katherine; Khashab 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Sa1524 A Meta-Analysis on the Role of Re

✍ Sethi, Saurabh; Sethi, Nidhi; Brown, Alphonso 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Use of Nafamostat Mesilate and Gabexate

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang-Ha Kim; Geun-Am Song; Jae-Sup Eum; Sang-Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

The safety and utility of prophylactic p

✍ Patrick T. F. Kennedy; Evangelos Russo; Naveenta Kumar; Nick Powell; Devinder Ba 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 247 KB

580 5 Fr Pancreatic Duct Stents Are Supe

✍ Afghani, Elham; Akshintala, Venkata S.; Khashab, Mouen; Hutfless, Susan; Kim, Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 329 KB

OC.11.1 PRELIMINARY RESULTS ON THE COMPA

✍ B. Mangiavillano; M. Mangano; E. Limido; G. Bernasconi; G. Spinzi; V. Terruzzi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB